Drug Trial Radar · NCT05478109
A Clinical Trial of XZP-3287 for Material Balance
Last checked: Nov 20, 2026Latest source record: Jul 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
10
Planned (sponsor's estimate)
Start
Aug 2, 2022
Primary completion
Jan 4, 2023
Study completion Jan 4, 2023
Sponsor
- Lead sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of \[14C\] XZP-3287
Conditions
- Healthy Male Subjects
Interventions
[14C]XZP-3287Drug
360 mg suspension containing 50µCi of \[14C\] XZP-3287
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK data for 14C-XZP-3287: CmaxTime frame: up to 15 days
- PK data for 14C-XZP-3287: AUClastTime frame: up to 15 days
- PK data for 14C-XZP-3287: AUCinfTime frame: up to 15 days
- PK data for 14C-XZP-3287: TmaxTime frame: up to 15 days
- Quantitative analysis of cumulative excretion and excretion rate in excreta (urine and faeces)Time frame: up to 15 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Gaobo Boren Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.